Routine clinical use of biomaterials requires to foster their production. This implies the reduction of their economical and ethical costs. Our aim is to act on the biocompatibility tests (ISO10993-6 EU norm) which are unsustainable for small-medium industries and for the society.


In this project we foster an unprecedented breakthrough in in-vivo optical imaging that will radically renew the biocompatibility tests of biomaterials.

This is based on the combination of three pillars:

1. 2-photon fabrication of microlenses and microstructures to visualize and host biomaterial specimens.

2. non-linear excitation microscopy in-vivo through the micro-lenses.

3. numerical simulations of the immune response to the biomaterials.

Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback
Feedback